Literature DB >> 17901199

Alternative translation initiation of human regulators of G-protein signaling-2 yields a set of functionally distinct proteins.

Steven Gu1, Annepa Anton, Samina Salim, Kendall J Blumer, Carmen W Dessauer, Scott P Heximer.   

Abstract

The regulator of G-protein signaling (RGS2) contains a characteristic RGS domain flanked by short amino and carboxyl terminal sequences. The RGS domain mediates inhibition of Galpha(q) and Galpha(i) signaling, whereas the amino terminal domain (NTD) directs interaction with adenylyl cyclases, G-protein-coupled receptors, and other signaling partners. Here, we identify a set of novel RGS2 protein products that differ with respect to their amino terminal architecture and functional characteristics. An RGS2 expression reporter cassette revealed four distinct open reading frames (ORFs) that can be expressed from the RGS2 NTD. We hypothesized that alternative translation initiation from four AUG codons corresponding to amino acid positions 1, 5, 16, and 33 could produce the observed RGS2 expression profile. Selective disruption of each AUG confirmed that alternate sites of translation initiation accounted for each of the observed products. Proteins derived from ORFs 1 to 4 showed no difference in Galpha(q) inhibitory potential or recruitment from the nucleus in response to Galpha(q) signaling. By contrast, RGS2 products initiating from methionines at positions 16 (ORF3) and 33 (ORF4) were impaired as inhibitors of type V adenylyl cyclase (ACV) compared with full-length RGS2. We predicted that regulation of the RGS2 expression profile would allow cells to adapt to changing signaling conditions. Consistent with this model, activation of Galpha(s)/ACV but not Galpha(q) signaling increased the relative abundance of the full-length RGS2 protein, suggesting that alternative translation initiation of RGS2 is part of a novel negative feedback control pathway for adenylyl cyclase signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901199     DOI: 10.1124/mol.107.036285

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

Review 1.  Non-canonical functions of RGS proteins.

Authors:  Nan Sethakorn; Douglas M Yau; Nickolai O Dulin
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

Review 2.  Regulators of G-protein signaling in the heart and their potential as therapeutic targets.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Circ Res       Date:  2011-07-22       Impact factor: 17.367

3.  Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels.

Authors:  Benita Sjögren; Sergio Parra; Lauren J Heath; Kevin B Atkins; Zie-Jian Xie; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2012-06-13       Impact factor: 4.436

4.  Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.

Authors:  Nicole K Littlejohn; Rick B Siel; Pimonrat Ketsawatsomkron; Christopher J Pelham; Nicole A Pearson; Aline M Hilzendeger; Beth A Buehrer; Benjamin J Weidemann; Huiping Li; Deborah R Davis; Anthony P Thompson; Xuebo Liu; Martin D Cassell; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

5.  Regulation of Smad-mediated gene transcription by RGS3.

Authors:  Douglas M Yau; Nan Sethakorn; Sebastien Taurin; Steven Kregel; Nathan Sandbo; Blanca Camoretti-Mercado; Anne I Sperling; Nickolai O Dulin
Journal:  Mol Pharmacol       Date:  2008-02-20       Impact factor: 4.436

6.  Association analysis of Rgs7 variants with panic disorder.

Authors:  Christa Hohoff; Anna Neumann; Katharina Domschke; Christian Jacob; Wolfgang Maier; Jürgen Fritze; Borwin Bandelow; Petra Krakowitzky; Matthias Rothermundt; Volker Arolt; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2008-09-02       Impact factor: 3.575

Review 7.  Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Trends Cardiovasc Med       Date:  2013-08-17       Impact factor: 6.677

8.  Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of Gq/11 signaling and vascular contraction.

Authors:  Stanley M Kanai; Alethia J Edwards; Joel G Rurik; Patrick Osei-Owusu; Kendall J Blumer
Journal:  J Biol Chem       Date:  2017-10-03       Impact factor: 5.157

9.  N-terminal proteomics and ribosome profiling provide a comprehensive view of the alternative translation initiation landscape in mice and men.

Authors:  Petra Van Damme; Daria Gawron; Wim Van Criekinge; Gerben Menschaert
Journal:  Mol Cell Proteomics       Date:  2014-03-12       Impact factor: 5.911

10.  Translational control by RGS2.

Authors:  Chau H Nguyen; Hong Ming; Peishen Zhao; Lynne Hugendubler; Robert Gros; Scot R Kimball; Peter Chidiac
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.